Determinants of prevalence, awareness, treatment and control of high LDL-C in TurkeyKaan Sözmen1, Belgin Ünal2, Sibel Sakarya3, Gönül Dinç4, Nazan Yardım5, Banu Ekinci6, Gül Ergör2
1Department of Public Health, Faculty of Medicine, Katip Çelebi University, İzmir-Turkey
2Department of Public Health, Faculty of Medicine, Dokuz Eylül University, İzmir-Turkey
3Department of Public Health, Faculty of Medicine, Marmara University, İstanbul-Turkey
4Department of Biostatistics and Medical Informatics, Faculty of Medicine, Celal Bayar University, Manisa-Turkey
5Departments of Obesity, Diabetes, Metabolic Diseases
6Chronic Diseases, Elderly Health and Disabled, Turkish Institute of Public Health, Ministry of Health of Turkey
Objective: High blood cholesterol is one of the main modifiable risk factors for cardiovascular diseases (CVDs). The aim of the study is to determine the factors associated with the prevalence, awareness, treatment, and control of high low-density lipoprotein-cholesterol (LDL-C) among adults aged ≥20 years in Turkey.Keywords: cholesterol, Framingham risk score, Turkey, coronary heart disease
Methods: We used data from Chronic Diseases and Risk Factors Survey conducted in 20112012. The presence of high LDL-C, lipid-lowering treatment eligibility, and achievement of target LDL-C were defined according to the third Adult Treatment Panel guidelines on treatment of high cholesterol. Multivariate logistic regression analyses were performed to determine the associations between participant characteristics and high LDL-C prevalence, awareness, treatment, and control.
Results: Framingham risk score categorization was performed for 13121 individuals aged ≥20 years. Approximately, 28% of the participants presented with high LDL-C. Among those with high LDL-C, 55.8% were aware of their situation; among those aware of high LDL-C, 46.9% were receiving lipidlowering medication, and 50.6% of individuals who were receiving treatment achieved target LDL-C levels on the basis of their coronary heart disease (CHD) risk. Control of high LDL-C was negatively associated with the presence of diabetes mellitus (odds ratio: 0.36, 95% CI: 0.270.49, p<0.001).
Conclusion: Despite the high awareness rates, there was a high proportion of adults who did not receive treatment or achieve recommended levels of LDL-C during treatment. The low treatment and control levels among individuals based on their CHD risk levels call for a better application of recommendations regarding personal preventive measures and treatments in Turkey. (Anatol J Cardiol 2016; 16: 000-00)
Kaan Sözmen, Belgin Ünal, Sibel Sakarya, Gönül Dinç, Nazan Yardım, Banu Ekinci, Gül Ergör. Determinants of prevalence, awareness, treatment and control of high LDL-C in Turkey. Anatol J Cardiol. 2016; 16(6): 370-384
Sorumlu Yazar: Kaan Sözmen, Türkiye